← Evidence map

ReviewCells2025

Survivin Interference and SurVaxM as an Adjunct Therapy for Glioblastoma Multiforme.

Willie James Elliott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40422257